NCT03398044View on ClinicalTrials.gov

Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions
Nasal ObstructionNasopharyngeal ObstructionSnoringApnea, ObstructiveHearing LossOtitis
Interventions
DRUG

Dexamethasone

Dexamethasone will be administered to patients randomised into the active treatment arm, in order to determine the influence upon PONV incidence.

DRUG

Placebo

Placebo will be administered to patients randomised into the control group arm.

Trial Locations (1)

70852

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT03398044 - Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy | Biotech Hunter | Biotech Hunter